Want to see MASS full AI Analyst Report?
MASS Stock Chart & Stats
$7.14
>-$0.01(-0.14%)
At close: 4:00 PM EDT
$7.14
>-$0.01(-0.14%)
Day’s Range― - ―
52-Week Range$5.03 - $10.52
Previous Close$7.13
Volume229.31K
Average Volume (3M)298.86K
Market Cap
$413.75M
Enterprise Value$229.69
Total Cash (Recent Filing)$101.53M
Total Debt (Recent Filing)$4.30M
Price to Earnings (P/E)―
Beta1.14
Next Earnings
Nov 16, 2026EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.93
Shares Outstanding41,333,706
10 Day Avg. Volume253,523
30 Day Avg. Volume298,861
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)1.32
Price to Sales (P/S)3.38
P/FCF Ratio-7.72
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$12.50Price Target Upside75.07% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)-0.4
Revenue Forecast (FY)$68.53M
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthA strong cash position and no debt provide durable financial flexibility to fund product development, sales expansion, and M&A without near‑term refinancing risk. This runway supports execution on recurring revenue initiatives and cushions against execution hiccups while margins scale.
Installed Base & Device MomentumA growing installed base and continuing device shipments indicate rising adoption of core instruments, which sustainably drives consumables, service contracts and cross‑sell opportunities. This durable commercial momentum supports predictable repeat revenue as devices remain in service.
High & Improving Product MarginsStable, mid‑to‑high 50s gross margins reflect strong product economics that can sustain profitability as scale grows. Margin improvement reduces cash burn and gives management room to invest in recurring subscription growth and commercial expansion while moving toward adjusted EBITDA breakeven.
Bears Say
Ongoing GAAP LossesMaterial GAAP losses and continued negative adjusted EBITDA, despite improvement, mean the company remains cash‑consumptive and reliant on its balance sheet or financing to invest. Persistent losses constrain returns on equity and increase execution risk if revenue/margin momentum slows.
Product‑Mix Margin PressureMix shifts toward recently acquired or discounted product deployments can structurally compress blended margins. If lower‑margin channels or early‑stage subscription hardware scale faster than higher‑margin offerings, sustaining corporate gross margins and the path to profitability becomes more challenging.
Dependence On Uncertain Large Defense OpportunityReliance on a sizable but unbooked defense program creates forecast volatility and execution dependency. If management expects material upside from such programs, delayed or failed awards could leave revenue and recurring targets underpenetrated, stressing profitability and capital plans.
908 Devices News
MASS FAQ
What was 908 Devices Inc.’s price range in the past 12 months?
908 Devices Inc. lowest stock price was $5.03 and its highest was $10.52 in the past 12 months.
What is 908 Devices Inc.’s market cap?
908 Devices Inc.’s market cap is $413.75M.
When is 908 Devices Inc.’s upcoming earnings report date?
908 Devices Inc.’s upcoming earnings report date is Nov 16, 2026 which is in 90 days.
How were 908 Devices Inc.’s earnings last quarter?
908 Devices Inc. released its earnings results on Aug 11, 2026. The company reported -$0.088 earnings per share for the quarter, beating the consensus estimate of -$0.142 by $0.054.
Is 908 Devices Inc. overvalued?
According to Wall Street analysts 908 Devices Inc.’s price is currently Undervalued.
Does 908 Devices Inc. pay dividends?
908 Devices Inc. does not currently pay dividends.
What is 908 Devices Inc.’s EPS estimate?
908 Devices Inc.’s EPS estimate is -0.12.
How many shares outstanding does 908 Devices Inc. have?
908 Devices Inc. has 41,333,706 shares outstanding.
What happened to 908 Devices Inc.’s price movement after its last earnings report?
908 Devices Inc. reported an EPS of -$0.088 in its last earnings report, beating expectations of -$0.142. Following the earnings report the stock price went up 13.75%.
Which hedge fund is a major shareholder of 908 Devices Inc.?
Currently, no hedge funds are holding shares in MASS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
908 Devices Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.50 (75.07% Upside)
$12.50 (75.07% Upside)
Blogger Sentiment
Bullish
MASS Sentiment 75%
Sector Average 61%
Sector Average 61%
Hedge Fund Trend
Increased
By 132.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 0.8%
Last 30 Days ▲ 0.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-3.90%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.04%
Trailing 12-Months
Company Description
908 Devices Inc.
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
MASS Company Deck
MASS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a constructive operational and commercial narrative with strong top-line growth (Q2 revenue +23%), clear product momentum across FTIR, MX908 and XplorIR, meaningful large orders and an accretive strategic acquisition (NIRLAB) showing early subscription traction. Profitability metrics are improving materially (adjusted EBITDA loss cut by ~50%, adjusted gross margin up ~85 bps) and the balance sheet is healthy with $101.5M in cash and no debt. Offsetting these positives are continuing GAAP losses, remaining negative adjusted EBITDA, margin pressure from some newer/lower-margin product volumes and uncertainty around the timing/path of the AVCAD defense opportunity (excluded from guidance). Overall, the positives — durable revenue growth, improving margins, strong device momentum and early recurring revenue from NIRLAB — outweigh the challenges, though execution risk on margins, recurring revenue scale and the AVCAD outcome remain items to monitor.View all MASS earnings summariesMASS Stock 12 Month Forecast
Average Price Target
$12.50
▲(75.07% Upside)
Technical Analysis
Senseonics Holdings
―
Quanterix
―
Nano-X Imaging
―
TriSalus Life Sciences
―
Cytek Biosciences
―
Ownership Overview
32.82% Insiders
11.57% Mutual Funds
7.39% Other Institutional Investors
34.36% Public Companies and
Individual Investors